UK markets open in 56 minutes

CVS Health Corporation (0HRS.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
84.77-2.07 (-2.39%)
At close: 6:52PM BST
Sign in to post a message.
  • D
    Derrick
    In the history of CVS since it went public yesterday's RSI was the highest it's ever been.

    This is going to pullback at least 5%.

    It's still way overbought with a current RSI of over 77.

    Let it come back down in the 60's before you buy.

    If you look at the history of CVS, it bounces back quick when it is oversold and retreats just as quick when it is overbought.
  • J
    John
    A perspective: $85 and change is only $4 above when Aetna deal closed 30 months ago. And today's market cap is-in my opinion-about what Aetna's market cap would be had Aetna remained a stand-alone company. Traction and momentum in other areas could soon push the CVS stock price to $100 plus. Investors have been in "show me" mode; that is changing. Got my CVS in the Aetna deal. It's been a frustrating ride, but I held.👍
  • m
    mike
    How many feel there will be a booster COVID shot later this year? Cause if there is one, then cvs will go over 💯 for sure!!
  • A
    Albert
    87 today, you would assume 90 by end of week, maybe more than 90 , this stock is on fire
  • m
    mike
    At eps of $7.56 (the lower end of their prediction) times a very conservative 14 multiple would price CVS share price to $105 for just this year alone. Cvs is still very undervalued!!
  • H
    Hairy G. Balls
    Will trade in range $80-93 'til Labor Day then kaboom to over $100 by XMAS! hints: Medicaid & Medicare expansion.
  • T
    Tony
    If nothing else, as others have said, this is a DIVIDEND stock with solid forward-looking potential. CVS is the new IBM or GE as I see it. Many stocks out there, but few as solid as CVS and they just completed the merger. It will take 2-3 years for them to get in gear, never mind managing business with a PANDEMIC!!!

    CVS is the Rodney Dangerfield of stocks. No respect.
  • D
    Doug
    Question. Yahoo is using GAAP per share earnings of 5.46 to compute a current PE of 15. But it seems on the board and in many published articles non-GAAP adjusted per share earnings are being used to calculate PE. I am assuming then from an investors standpoint if PE is being used to make a purchase or sale decision, adjusted earnings is appropriate? Any thoughts let me know. Thanks
  • S
    Sam
    Eight quarters in a row beat analyst estimates and yet at FPE of 10 and dividend yield of 2.57%, CVS gets no respect! It should be 120+ by now a little more than what it was in 2015.
  • J
    John
    I've read the transcript of today's earnings call. I'll go out on a limb and say that I think that the stock will get traction...finally...and trend up. It's time! Minute Clinics catching on and 800 HealthHubs are open for biz and more on the way. The only negative that I see is that CVS is missing out on front store opportunities... financials not disclosed. Today's stock price reached the basis of my stock acquired in the Aetna deal...a long way to go to get that investment up to par...$100 plus. Mildly bullish for a change.
  • H
    Howie
    How can one not want to "hide out" in CVS picking up 2.5% dividend at a PE multiple of 10, vs an S&P 500 multiple of 22 and a yield of 1.45%?
  • H
    Hairy G. Balls
    1 year target has been revised to 91.25 on yahoo! I say over $100 babe!
  • A
    Althehumbleinvestor
    Ok, ladies and gentlemen! Here is the status update! All good in CVS land, with market rotation into value and street finally recognizing value proposition by integrated CVS/Aetna asset base we could be looking at $90 to $100 stock by year end! I think this probably needs to consolidate a bit before next leg up! This company is still significantly undervalued! $8x12=$96 minimum!!!
  • S
    Sam
    2022 EPS $8.10 x 15 (conservative PE ratio)= $121.50 target price. COVID is not going away - worldwide new variants will pop up and new cases will pop up again. Health care industry (drug manufacturers and insurance companies) should do very well over the next couple of years.
  • K
    KENNETH
    Has anyone sold any shares yet , myself I am wanting quite a bit more before I even consider selling any shares at all
  • H
    Hairy G. Balls
    Buy on the Medicaid & Medicare expansion!!!!!!!!!!!!!!!!!!!!!
  • A
    Albert
    judging from PM, may be today but DOW is down as well, it will be back soon
  • M
    Max
    So, the question becomes, should I sell?

    I bought at $53 and change. Up almost 60% in 13 months. Is there more upside? Sure. But is there more upside in a stock like QDEL? You betcha. More upside and more a much bigger CAGR. Or maybe it's time to flip into CRSP now that it's basing out around $110.
  • J
    JosephS
    this stock is almost a no brained. they have been delivering the covid-19 vaccine. they pass out tons of coupons during distribution of the vaccine bringing in more revenue. their investment in the healthcare field is starting to pay off. this is going up over $110 by the end of the year.
  • r
    rick
    the past several quarters, beat earning, revenues, adjust guidance positive each time, then it turns red and does not recover until 1 1/2 months before next earnings and repeats the cycle. I used to work with Aetna before CVS purchase, stock was running close to $205 a share....CVS has to bust out the gates sometime...maybe this is the time. Game ON!